BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 6357643)

  • 1. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment].
    Hintner H; Schuler G; Fritsch P
    Hautarzt; 1982 Jun; 33(6):310-4. PubMed ID: 6179897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acquired epidermolysis bullosa. A clinico-pathologic study].
    Rappersberger K; Konrad K; Schenk P; Tappeiner G
    Hautarzt; 1988 Jun; 39(6):355-62. PubMed ID: 3042704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology].
    Schenk P; Konrad K
    Laryngol Rhinol Otol (Stuttg); 1983 Oct; 62(10):456-62. PubMed ID: 6358736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa acquisita in childhood.
    Callot-Mellot C; Bodemer C; Caux F; Bourgault-Villada I; Fraitag S; GoudiƩ G; Heller M; de Prost Y; Prost C
    Arch Dermatol; 1997 Sep; 133(9):1122-6. PubMed ID: 9301589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa acquisita and Crohn's disease. A case report with immunological and electron microscopic studies.
    Labeille B; Gineston JL; Denoeux JP; Capron JP
    Arch Intern Med; 1988 Jun; 148(6):1457-9. PubMed ID: 2897835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural and immuno-electron microscopic study in a case of epidermolysis bullosa acquisita.
    Nilsen R; Livden J; Matre R
    Acta Pathol Microbiol Scand A; 1981 Nov; 89(6):451-4. PubMed ID: 7336921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
    Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
    Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid.
    Feliciani C; Di Muzio M; Mohammad Pour S; Allegretti T; Amerio P; Toto P; Coscione G; Proietto G; Amerio P
    J Eur Acad Dermatol Venereol; 1998 May; 10(3):243-7. PubMed ID: 9643329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of epidermolysis bullosa acquisita.
    Richter BJ; McNutt NS
    Arch Dermatol; 1979 Nov; 115(11):1325-8. PubMed ID: 389167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis bullosa acquisita with negative direct immunofluorescence.
    Lacour JP; Juhlin L; el Baze P; Ortonne JP
    Arch Dermatol; 1985 Sep; 121(9):1183-5. PubMed ID: 3899018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.
    Epstein A; Hendrick SJ; Sanchez RL; Solomon AR; Fine JD
    Arch Dermatol; 1988 Feb; 124(2):244-9. PubMed ID: 3277544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis bullosa acquisita with electron microscopical studies.
    Gibbs RB; Minus HR
    Arch Dermatol; 1975 Feb; 111(2):215-20. PubMed ID: 1115511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
    Gardner KM; Crawford RI
    J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
    Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
    Woodley DT; O'Keefe EJ; McDonald JA; Reese MJ; Briggaman RA; Gammon WR
    J Clin Invest; 1987 Jun; 79(6):1826-30. PubMed ID: 3584471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histology of supepidermal bullous dermatoses].
    Megahed M
    Verh Dtsch Ges Pathol; 1996; 80():223-8. PubMed ID: 9065014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.